ATHN 2: Factor Switching Study

NCT02546622 · clinicaltrials.gov ↗

COMPLETED

Status

310

Enrollment

NETWORK

Sponsor class

Conditions

Hemophilia

Interventions

BIOLOGICAL: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013
BIOLOGICAL: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013

Sponsor

American Thrombosis and Hemostasis Network

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]